Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a small update to the page's documentation or backend text.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe site revision updated from v3.6.4 to v3.6.5, indicating a new build of the website. This update reflects a backend or UI software update rather than content changes.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now displays revision v3.6.4, replacing v3.6.3. This reflects a small platform or content-management update and does not indicate changes to the study information.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page was published, without changes to the study details.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now shows that recruitment is no longer ongoing. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was reformatted, with a new Revision: v3.6.0 note.SummaryDifference0.5%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.